Literature DB >> 880964

Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductase.

R C Jackson, D Niethammer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 880964     DOI: 10.1016/0014-2964(77)90118-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  17 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells.

Authors:  R S McIvor; C C Simonsen
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

3.  The development of resistance to methotrexate in a mouse melanoma cell line. I. Characterisation of the dihydrofolate reductases and chromosomes in sensitive and resistant cells.

Authors:  C J Bostock; E M Clark; N G Harding; P M Mounts; C Tyler-Smith; V van Heyningen; P M Walker
Journal:  Chromosoma       Date:  1979       Impact factor: 4.316

4.  Overproduction of dihydrofolate reductase and gene amplification in methotrexate-resistant Chinese hamster ovary cells.

Authors:  W F Flintoff; M K Weber; C R Nagainis; A K Essani; D Robertson; W Salser
Journal:  Mol Cell Biol       Date:  1982-03       Impact factor: 4.272

5.  Isolation and expression of an altered mouse dihydrofolate reductase cDNA.

Authors:  C C Simonsen; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

6.  Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia.

Authors:  J D Borsi; T Revesz; D Schuler
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 7.  Chemotherapeutic drug resistance in the management of head and neck cancer.

Authors:  H Bier
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

8.  The in vivo distribution of methotrexate between plasma and erythrocytes.

Authors:  W H Steele; J F Stuart; J R Lawrence; C A McNeill
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  Systemic resistance to methotrexate in transgenic mice carrying a mutant dihydrofolate reductase gene.

Authors:  L M Isola; J W Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Interactions between inhibitors of dihydrofolate reductase.

Authors:  K Bowden; A D Hall; B Birdsall; J Feeney; G C Roberts
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.